WebKYMR Kymera Therapeutics Inc Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 4 WATERTOWN, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel smal... WebMar 31, 2024 · Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. ... Ticker Symbol: KYMR: Exchange: NASDAQ: Fiscal Year: January - December: Reporting …
Kymera Therapeutics Inc (KYMR) AAII Stock Evaluator
WebApr 10, 2024 · Ticker Symbol Financial Performance Financial Statements Analyst Forecast According to 24 analysts, the average rating for KYMR stock is "Buy." The 12-month stock price forecast is $56.74, which is an increase of 82.80% from the latest price. Price Target $56.74 ( 82.80% upside) Analyst Consensus: Buy Stock Forecasts News All Videos Press … WebWATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel... See the company profile for Kymera Therapeutics, Inc. (KYMR) including … Find out all the key statistics for Kymera Therapeutics, Inc. (KYMR), including … See Kymera Therapeutics, Inc. (KYMR) stock analyst estimates, including … View the basic KYMR option chain and compare options of Kymera … Holder Shares Date Reported % Out Value; Atlas Venture Life Science Advisors, LLC … See Kymera Therapeutics, Inc. (KYMR) Environment, Social and Governance … Find the latest Kymera Therapeutics, Inc. (KYMR) stock quote, history, news and … Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial … The latest news and headlines from Yahoo! News. Get breaking news stories and in … WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Kymera … hermes sales salary
Kymera Therapeutics (Nasdaq:KYMR) - Simply Wall St
WebJul 9, 2024 · Kymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To Patients - Kymera to receive $150 million upfront with more than $2 billion in ... WebMenu is for informational purposes only. Menu items and prices are subject to change without prior notice. For the most accurate information, please contact the restaurant directly before visiting or ordering. WebJun 28, 2024 · WATERTOWN, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel... hermes samarcande chess set